Finch Therapeutics Group, Inc. (FNCH) Financials
FNCH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 59.5 million | 33.7 million |
2023-06-30 | 66.9 million | 39.0 million |
2023-03-31 | 79.0 million | 46.1 million |
2022-12-31 | 162.9 million | 67.2 million |
FNCH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.3 million | 335000 |
2023-06-30 | -9.2 million | 300000 |
2023-03-31 | -13.4 million | 1.2 million |
2022-12-31 | -14.3 million | 1.8 million |
FNCH Net Income
No data available :(
FNCH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 28.8 million | - | 30.8 million |
2023-06-30 | 34.1 million | - | 31.0 million |
2023-03-31 | 41.7 million | - | 36.1 million |
2022-12-31 | 71.0 million | - | 37.7 million |
FNCH Shares Outstanding
FNCH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | - | 3.7 million | - |
2023-06-30 | - | 203000 | 8.9 million | - |
2023-03-31 | 14000 | 8.6 million | 9.6 million | - |
2022-12-31 | 51000 | 16.6 million | 10.9 million | - |
FNCH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 52000 |
2023-06-30 | - | 57000 |
2023-03-31 | 107000 | 1.4 million |
2022-12-31 | 8000 | 1.4 million |
FNCH
Price: $2.33
52 week price:
Earnings Per Share: -46.59 USD
P/E Ratio: -0.04
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 136300
Market Capitalization: 3.3 million